Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies:a phase I clinical study
clinical、modified、study、phase、cell、with、allogeneic、cd7-positive、cd7-targeting、efficacy
32
R6;TP391;TP273
2023-01-13(万方平台首次上网日期,不代表论文的发表时间)
共13页
995-1007